Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8**

Creative Commons License

Milosevich N., Wilson C. R., Brown T. M., ALPSOY A., Wang S., Connelly K. E., ...Daha Fazla

CHEMMEDCHEM, cilt.16, sa.19, ss.3027-3034, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 19
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1002/cmdc.202100262
  • Dergi Adı: CHEMMEDCHEM
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Index Chemicus (IC)
  • Sayfa Sayıları: ss.3027-3034
  • Orta Doğu Teknik Üniversitesi Adresli: Hayır

Özet

Methyllysine reader proteins bind to methylated lysine residues and alter gene transcription by changing either the compaction state of chromatin or by the recruitment of other multiprotein complexes. The polycomb paralog family of methyllysine readers bind to trimethylated lysine on the tail of histone 3 (H3) via a highly conserved aromatic cage located in their chromodomains. Each of the polycomb paralogs are implicated in several disease states. CBX6 and CBX8 are members of the polycomb paralog family with two structurally similar chromodomains. By exploring the structure-activity relationships of a previously reported CBX6 inhibitor we have discovered more potent and cell permeable analogs. Our current report includes potent, dual-selective inhibitors of CBX6 and CBX8. We have shown that the -2 position in our scaffold is an important residue for selectivity amongst the polycomb paralogs. Preliminary cell-based studies show that the new inhibitors impact cell proliferation in a rhabdoid tumor cell line.